Form 4: Artiva Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Christopher Horan, Chief Tech Operations Officer of Artiva Biotherapeutics, Inc., sold 10,366 shares of common stock on September 3, 2026 for $11.16 per share.
Summary
- Open-market sale: disposed of 10,366 Common Stock at $11.16 ($115,638) on September 3, 2026; holds 283,084 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $115,638 of stock on the open market.
Insider Transactions
Christopher Horan — Officer (Chief Tech Operations Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 10,366 | $11 | $115.6K | 283,084 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (10,366 shares) |
Keywords
insider transaction, Form 4, ARTV, Artiva Biotherapeutics, Inc., bearish, Christopher Horan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.